Customized Biospecimen Collection and Analysis
At Ace Therapeutics, we specialize in providing customized biospecimen collection and analysis services tailored to the unique demands of preclinical hematologic disease research. Our services are designed to generate high-quality, well-annotated biospecimens that enable in-depth molecular, cellular, and biochemical analyses in a wide array of preclinical models. With a focus on reliability, scalability, and scientific precision, our biospecimen services support biomarker identification, mechanism-of-action studies, and therapeutic validation.
Blood diseases exhibit complex pathophysiology influenced by genetic, molecular, and environmental factors. Standardized biospecimen protocols often fail to capture disease-specific nuances. Ace Therapeutics addresses this gap through
We support diverse sample types and collection strategies to accommodate various stages of preclinical hematology studies.
| Sample Types | Details |
| Peripheral Blood | Serial collection for hematological and immunophenotyping studies |
| Bone Marrow | Aspiration or isolation from femur/tibia for progenitor and stem cell analysis |
| Plasma and Serum | Separated using validated centrifugation protocols for proteomic and metabolomic assays |
| Spleen Tissue | Dissected for immunological or gene expression profiling |
| Longitudinal Sampling | Enables temporal biomarker analysis in progressive or therapeutic study designs |
We ensure metadata-rich biobanking with full traceability, including animal identifiers, treatment regimens, timepoints, and environmental parameters.
We offer integrated downstream analysis optimized for hematologic biospecimens, ensuring maximum data extraction and translational value.
Our extraction protocols are optimized for hematologic samples, ensuring high-quality RNA, DNA, and protein even from small-volume or challenging specimens.
We manage biospecimen handling with meticulous attention to detail to maintain sample integrity throughout the study lifecycle.
All collection and processing steps are coordinated to support reproducibility and downstream analysis compatibility.
| Application Area | How Our Biospecimens Support It |
| Biomarker Discovery | Longitudinal sample collection for tracking changes over time |
| Therapeutic Mechanism Studies | Isolation of specific immune or progenitor cell populations for pathway analysis |
| Pharmacodynamics Evaluation | Correlation of biomolecular changes with drug exposure |
| Molecular Diagnostics Development | High-integrity DNA/RNA for assay development |
| Translational Research | Bridging in vivo models to human disease mechanisms through multi-omics approaches |
Contact us today to discuss how our customized biospecimen collection and analysis services can align with your project goals.
What types of animal models do you support for biospecimen collection?
We support a wide variety of hematologic disease models, including murine models of leukemia, anemia, lymphoma, and bone marrow failure syndromes. Custom model integration is also available.
Can you accommodate serial blood collections in longitudinal studies?
Yes, we provide serial peripheral blood collection to support time-course analyses, ideal for biomarker tracking or therapeutic monitoring.
What types of analyses can you perform on collected biospecimens?
We offer hematologic, biochemical, molecular, and proteomic analyses, including custom assay integration upon request.
How do you ensure sample integrity during processing and storage?
We use validated protocols for collection and storage, along with barcode-based sample tracking and environment-controlled biobanking facilities.
Can biospecimens be stored for future use or re-analysis?
Yes, long-term storage is available, with full traceability and metadata for each sample to enable retrospective studies.
Make Order
Experimental Scheme
Implementation
Conclusion
Ace Therapeutics specializes in preclinical research for hematologic diseases, providing reliable models and cutting-edge analytical support to advance therapeutic discovery.
With years of scientific experience, we offer integrated solutions that help biopharma teams turn early-stage ideas into robust preclinical outcomes.